Background. Intranasal
steroid provides an efficient nonsurgical alternative to
adenoidectomy for theimprovement of adenoid
nasal obstruction. Objective. To demonstrate the role of intranasal
steroid in the prevention of adenoid regrowth after
adenoidectomy. Methods. Prospective randomized controlled study. Two hundred children after
adenoidectomy were divided into 2 groups. Group I received postoperative intranasal
steroid and group II received postoperative intranasal saline spray. Both medications were administered for 12 weeks postoperatively. Patients were followed up for 1 year. Followup was done using the nasopharyngeal lateral X-rays, reporting the degree of the symptoms. Results. Significant difference between both groups after 6 months and after 1 year. The intranasal
steroid group had significantly lower score after 6 months and after 1 year as regards
nasal obstruction, nasal discharge, and
snoring than the intranasal saline group. 2 weeks postoperatively, there was no difference between both groups as regards
nasal obstruction, discharge, or
snoring. As regards lateral radiographs, there was statistically significant difference between both groups 1 year but not 6 months postoperatively. Conclusion. Factors influencing the outcome of intranasal
steroids therapy in the prevention of adenoid regrowth have not been identified. However, this treatment may obtain successful results in children to avoid readenoidectomy.